Stevanato Group S.p.A (STVN) Total Current Liabilities (2020 - 2025)
Stevanato Group S.p.A (STVN) posted quarterly Total Current Liabilities of $623.8 million for Q4 2025, up 22.26% year-over-year from $510.2 million in Q4 2024, and up 22.26% quarter-over-quarter from $510.2 million in Q4 2024.
Stevanato Group S.p.A (STVN) Total Current Liabilities (2020 - 2025) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Total Current Liabilities for 6 consecutive years, with $623.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 22.26% year-over-year to $623.8 million; the TTM figure through Dec 2025 stood at $623.8 million (up 22.26% YoY), while the FY2025 annual figure was $623.8 million, up 22.26% from the prior year.
- Total Current Liabilities improved to $623.8 million in Q4 2025 per STVN's latest filing, from $510.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $623.8 million in Q4 2025 and bottomed at $386.3 million in Q3 2021.
- Historically, Total Current Liabilities has averaged $485.2 million across 5 years, with a median of $471.9 million in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 30.97% — and 2024, when it decreased 17.44%.
- Stevanato Group S.p.A's Total Current Liabilities stood at $387.4 million in 2021, then rose by 21.81% to $471.9 million in 2022, then surged by 30.97% to $618.0 million in 2023, then fell by 17.44% to $510.2 million in 2024, then advanced by 22.26% to $623.8 million in 2025.
- Business Quant data shows STVN's Total Current Liabilities at $623.8 million in Q4 2025, $510.2 million in Q4 2024, and $618.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.59 Bn | 51.72 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.69 Bn | 32.22 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.14 Bn | 26.46 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.05 Bn | 24.62 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.41 Bn | 15.01 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Stevanato Group S.p.A | 6.17 Bn | 6.06 Bn | 100.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 623.79 Mn |
| Dec 31, 2024 | 510.23 Mn |
| Dec 31, 2023 | 618.01 Mn |
| Dec 31, 2022 | 471.87 Mn |
| Dec 31, 2021 | 387.37 Mn |
| Sep 30, 2021 | 386.33 Mn |
| Jun 30, 2021 | 398.71 Mn |
| Dec 31, 2020 | 376.97 Mn |